Navigation Links
Breast cancer patients prefer silicone over saline implants after mastectomy

A new study has found that women who receive silicone implants after a double mastectomy are more satisfied with their breasts than women who receive saline implants. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help physicians and breast cancer survivors as they together make decisions related to postmastectomy reconstructive surgery.

Women who have one or both of their breasts removed as a treatment for breast cancer may wish to undergo breast reconstructive surgery with implants. Such postmastectomy implants may be filled with either saline (salt water) or silicone gel, and while both types have been approved by the US Food and Drug Administration, the safety and effectiveness of breast implants remain under close scrutiny. In addition to safety and efficacy, patient satisfaction and quality of life are also important considerations when comparing implant types. To this end, Colleen McCarthy, MD, of Memorial Sloan-Kettering Cancer Center in New York City led a team that surveyed 672 women who had undergone postmastectomy reconstructive surgery with implants at one of three centers in North America.

A total of 472 patients in the study completed questionnaires. In 176 women, silicone implants were placed; in 306, saline implants were used. The investigators found that patients with silicone implants were more satisfied with their reconstructed breasts than patients with saline implants. Receiving radiation therapy after a mastectomy had a significantly negative effect on breast satisfaction in both silicone and saline implant recipients. In addition, for women who received either silicone or saline implants, satisfaction diminished over time.

"We now know that women who elect to proceed with the placement of a silicone implant report higher satisfaction with their reconstructed breasts than those who choose saline implants," said Dr. McCarthy. "It also appears that patient satisfaction with postmastectomy implant-based reconstruction is generally high and that individual treatment variablessuch as implant typeexplain only a relatively small amount of the variance. Patient counseling should reflect these realities in order to reassure patients that high satisfaction may be obtained with both saline and silicone implants," she added.


Contact: Jennifer Beal

Related biology news :

1. Even the sickest babies benefit from breast-feeding
2. Consuming vegetables linked to decreased breast cancer risk in African-American women
3. Clue to unusual drug-resistant breast cancers found
4. Breast density linked to increased risk of subsequent breast cancer
5. Black mothers cite lack of desire as top reasons for not breastfeeding
6. Breast cancer diagnostic delay depends more on race than insurance
7. Decreased survival for Puerto Rican women with triple-negative breast cancer subtype
8. Racial differences in breast cancer treatment persist despite similar economics
9. Marshall University researchers awarded more than $1 million for breast cancer studies
10. Fat stem cells safe for breast reconstruction when cancer is dormant, says Pitt team
11. Alcohol consumption after breast cancer diagnosis may increase recurrence risk
Post Your Comments:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... ... November 30, 2015 , ... ... exhibition Jurassic World: The Exhibition, opening in March 2016 at Melbourne Museum in ... worldwide tour including several North American tour dates. The Exhibition is based on ...
(Date:11/30/2015)... -- HUYA Bioscience International, the leader in accelerating global development ... announced it has signed a Memorandum of Understanding with ... between KDDF and HUYA with the ultimate goal of ... the global market. China,s ... preclinical and clinical stage compounds. The company advances the ...
(Date:11/30/2015)... 30, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ... immune therapies for solid tumor cancers, announced today that ... director, and the Company welcomes Neil Woodford,s ... recent anonymous internet report on NW Bio.  The Company,s ... Linda Powers stated, "We agree with Mr. Woodford ...
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
Breaking Biology Technology: